Terms: = Liver cancer AND NUP98, NUP196, 4928, ADIR2, ENSG00000110713
4 results:
1. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
[TBL] [Abstract] [Full Text] [Related]
2. Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis.
Hiraoka A; Kumada T; Kariyama K; Takaguchi K; Atsukawa M; Itobayashi E; Tsuji K; Tajiri K; Hirooka M; Shimada N; Shibata H; Ishikawa T; Ochi H; Tada T; Toyoda H; Nouso K; Tsutsui A; Itokawa N; Imai M; Joko K; Hiasa Y; Michitaka K;
Cancer Med; 2019 Jan; 8(1):137-146. PubMed ID: 30575325
[TBL] [Abstract] [Full Text] [Related]
3. A retrospective population based cohort study of access to specialist palliative care in the last year of life: who is still missing out a decade on?
Rosenwax L; Spilsbury K; McNamara BA; Semmens JB
BMC Palliat Care; 2016 May; 15():46. PubMed ID: 27165411
[TBL] [Abstract] [Full Text] [Related]
4. Nuclear pore component nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes.
Singer S; Zhao R; Barsotti AM; Ouwehand A; Fazollahi M; Coutavas E; Breuhahn K; Neumann O; Longerich T; Pusterla T; Powers MA; Giles KM; Leedman PJ; Hess J; Grunwald D; Bussemaker HJ; Singer RH; Schirmacher P; Prives C
Mol Cell; 2012 Dec; 48(5):799-810. PubMed ID: 23102701
[TBL] [Abstract] [Full Text] [Related]
